Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis
- 20 January 2007
- journal article
- clinical trial
- Published by Springer Nature in Clinical Rheumatology
- Vol. 26 (9), 1495-1498
- https://doi.org/10.1007/s10067-007-0539-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Insulin resistance and impaired beta cell function in rheumatoid arthritisArthritis & Rheumatism, 2006
- Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapyScandinavian Journal of Rheumatology, 2006
- Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.2005
- Definition of Metabolic SyndromeCirculation, 2004
- Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.2002
- Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot studyArthritis Research & Therapy, 2002
- The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in menDiabetes Care, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996
- Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989